Market Indices
Sector Heatmap
PWS — Pacer WealthShield ETF
Cboe BZXPacer WealthShield ETF
- O
- 32.44
- H
- 32.44
- L
- 32.20
- V
- 6.66K
PWS — Latest News & Headlines
10 StoriesPowersoft (BIT:PWS) Stock Faces Revenue Growth And Thinner Margins - Simply Wall Street
Powersoft (BIT:PWS) Stock Faces Revenue Growth And Thinner Margins Simply Wall Street
Understanding the Setup: (PWS) and Scalable Risk - Stock Traders Daily
Understanding the Setup: (PWS) and Scalable Risk Stock Traders Daily
Studies will track real-world use of a treatment for intense hunger and hear from caregivers. - Stock Titan
Studies will track real-world use of a treatment for intense hunger and hear from caregivers. Stock Titan
AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Before the October 13, 2026 Lead Plaintiff Deadline - Morningstar
AARD Stock News: Robbins LLP Reminds Aardvark Therapeutics, Inc. Stockholders to Contact the Firm Before the October 13, 2026 Lead Plaintiff Deadline Morningstar
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD - FinancialContent
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD FinancialContent
Neurocrine advances research on VYKAT XR for Pr... - Pluang
Neurocrine advances research on VYKAT XR for Pr... Pluang
Understanding the Setup: (PWS) and Scalable Risk - Stock Traders Daily
Understanding the Setup: (PWS) and Scalable Risk Stock Traders Daily
An officer’s options will be restored as Bright Minds (DRUG) reverses a 44,500-share exercise. - Stock Titan
An officer’s options will be restored as Bright Minds (DRUG) reverses a 44,500-share exercise. Stock Titan
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) The Manila Times
Neurocrine Biosciences stock fell 1.4 percent before research event - AD HOC NEWS
Neurocrine Biosciences stock fell 1.4 percent before research event AD HOC NEWS